Page last updated: 2024-08-22

actinium and Lymphoma

actinium has been researched along with Lymphoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cabassa, C; Flombaum, CD; Jaggi, JS; Kappel, BJ; McDevitt, MR; Scheinberg, DA; Sgouros, G	1
Bander, NH; Borchardt, P; Curcio, MJ; Frank, RK; Lai, LT; Ma, D; McDevitt, MR; Miederer, M; Pellegrini, V; Scheinberg, DA; Simon, J; Wu, K	1

Other Studies

2 other study(ies) available for actinium and Lymphoma

Article	Year
Efforts to control the errant products of a targeted in vivo generator. Cancer research, 2005, Jun-01, Volume: 65, Issue:11 Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Chelating Agents; Female; Francium; Immunotoxins; Kidney; Lymphoma; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Radioimmunotherapy; Succimer; Unithiol	2005
Tumor therapy with targeted atomic nanogenerators. Science (New York, N.Y.), 2001, Nov-16, Volume: 294, Issue:5546 Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Female; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Linear Energy Transfer; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Survival Rate; Tumor Cells, Cultured	2001

Article

Year

Efforts to control the errant products of a targeted in vivo generator.

Cancer research, 2005, Jun-01, Volume: 65, Issue:11

Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Chelating Agents; Female; Francium; Immunotoxins; Kidney; Lymphoma; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Radioimmunotherapy; Succimer; Unithiol

2005

Tumor therapy with targeted atomic nanogenerators.

Science (New York, N.Y.), 2001, Nov-16, Volume: 294, Issue:5546

Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Female; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Linear Energy Transfer; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Survival Rate; Tumor Cells, Cultured

2001